IL23 Promotes Antimicrobial Pathways in Human Macrophages, Which Are Reduced With the IBD-Protective IL23R R381Q Variant is a research paper published in Cellular and Molecular Gastroenterology and Hepatology (2020). On theSindex it has a DataRank of 0. It has been cited 32 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: DK099097
National Institutes of Health
Grant: DK106593
National Institutes of Health
Grant: P30-DK034989
NIDDK NIH HHS
Grant: R01 DK099097
NIDDK NIH HHS
Grant: R01 DK106593
NIDDK NIH HHS
Grant: P30 DK034989
NIDDK NIH HHS
Grant: U01 DK062422
National Institutes of Health
Grant: 5R01DK106593-05
Integrative Genomic Analyses of Macrophages in Crohns Disease
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-BIO/29266/2017
Deep Drug Discovery and Deployment
National Institutes of Health
Grant: 5P30DK034989-22
Pilot and Feasibility Program
National Institutes of Health
Grant: 2R01DK099097-06A1
Functional outcomes of inflammatory bowel disease associated variants
FWCI
1.29
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals